
#MiCheck® Prostate is a novel #Australian technology and a risk score for aggressive prostate cancer. It's a lead product in the pipeline of @MinomicInt
Macquarie Park, Sydney
Joined April 2017
- Tweets149
- Following29
- Followers21
- Likes786
MiCheck® retweeted
We had the opportunity to share Minomic’s journey from genesis of the company to launch of MiCheck® Prostate in the US market with @360DxNews, a leading media outlet for the #diagnostics industry.
Subscribe to 360Dx to read the full article: 360dx.com/cancer/australian-…
MiCheck® retweeted
The number of men being diagnosed with #ProstateCancer is expected to increase by as much as 43% between now and 2040. Early and accurate diagnosis is key to boosting survival rates. MiCheck® Prostate is designed to better-detect aggressive prostate cancer.
MiCheck® retweeted
View the presentation of CEO Brad Walsh @drbrad69 on MiCheck® Prostate in the video linkedin.com/feed/update/urn…
#ProstateCancer
MiCheck® retweeted
Minomic is pleased to be part of the Australian Government vision to build sovereign capability. Read more: minomic.com/federal-governme…
#ProstateCancer #Investment #MedTech
MiCheck® retweeted
According to Dr @LoebStacy, younger men who consume healthy #plantbased foods, dramatically lower their risk of developing advanced #ProstateCancer
healio.com/news/primary-care…
MiCheck® retweeted
Minomic is thrilled to cooperate with the #CLIAx team that allows us to tap into the expertise in laboratory testing. It is a ‘soft landing’ site to enter the U.S. market for MiCheck Prostate test rollout. minomic.com/micheck-prostate…
MiCheck® retweeted
These findings highlight the importance of considering mental wellbeing during follow-up for early recognition and treatment of #ProstateCancer
sciencedirect.com/science/ar…
MiCheck® retweeted
Widowers are more likely to be diagnosed with advanced #ProstateCancer
medicalxpress.com/news/2021-…
MiCheck® retweeted
Black American military veterans with #aggressive #ProstateCancer who would benefit from surgery or radiation are less likely to get those treatments than men of other races, despite equal access to health care, a new study finds.
webmd.com/prostate-cancer/ne…
MiCheck® retweeted
Poor patients with low household #income have worse #ProstateCancer at diagnosis. These patients have different goals of care which impact their choice of treatment.
docwirenews.com/gu-oncology-…
MiCheck® retweeted
Association between #environmental quality and #ProstateCancer stage at diagnosis
Association between environmental quality and prostate cancer stage at diagnosis
nature.com/articles/s41391-0…
MiCheck® retweeted
This increase in the incidence rates appears to be related to an increased life expectancy. Increasing incidence rate trends in developing countries are likely due to improved access to medical care as well as increased documentation and reporting of cases.
MiCheck® retweeted
We are thrilled to announce that Minomic and GloriousMed executed an agreement formally launching the commercialization pathway for MiCheck® Prostate, in mainland China.
Discover more: minomic.com/minomic-enters-i…
@drbrad69
@micheck_test
#ProstateCancer
MiCheck® retweeted
A recent study shows an expansion of #Medicare in the US would improve #ProstateCancer outcomes for the #elderly
docwirenews.com/docwire-pick…
MiCheck® retweeted
On 24 March 2021 at Senate Alcove, Parliament House Canberra, Dr Brad Walsh, CEO of Minomic International Ltd, opened the innovations panel discussion.
Discover more: pathologytechnology.org.au/C…
MiCheck® retweeted
Depression common after #ProstateCancer diagnosis, incidence higher in #BlackMen. #Depression in Black patients was also associated with increased mortality. oncologynurseadvisor.com/hom…











